Jeff Nagge

426 total citations
14 papers, 272 citations indexed

About

Jeff Nagge is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Jeff Nagge has authored 14 papers receiving a total of 272 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 4 papers in Internal Medicine and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Jeff Nagge's work include Atrial Fibrillation Management and Outcomes (5 papers), Blood Pressure and Hypertension Studies (5 papers) and Venous Thromboembolism Diagnosis and Management (4 papers). Jeff Nagge is often cited by papers focused on Atrial Fibrillation Management and Outcomes (5 papers), Blood Pressure and Hypertension Studies (5 papers) and Venous Thromboembolism Diagnosis and Management (4 papers). Jeff Nagge collaborates with scholars based in Canada and United States. Jeff Nagge's co-authors include Jack Hirsh, Mark Crowther, Cynthia L. Richard, Navindra Persaud, Muhammad Mamdani, Zhan Yao, Irfan A. Dhalla, David N. Juurlink, Tara Gomes and Chelsea Hellings and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Internal Medicine and Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy.

In The Last Decade

Jeff Nagge

11 papers receiving 254 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeff Nagge Canada 7 160 97 58 43 34 14 272
Carmen Suárez Fernández Spain 11 215 1.3× 69 0.7× 20 0.3× 26 0.6× 17 0.5× 38 306
Amiee Kang United States 13 288 1.8× 142 1.5× 48 0.8× 8 0.2× 7 0.2× 31 399
Antonio Zapatero Spain 8 74 0.5× 40 0.4× 30 0.5× 33 0.8× 42 1.2× 11 307
Kadhim Sulaiman Oman 11 265 1.7× 18 0.2× 67 1.2× 13 0.3× 26 0.8× 27 355
José Polo García Spain 9 266 1.7× 54 0.6× 45 0.8× 27 0.6× 20 0.6× 40 328
Peter Dodek Canada 6 47 0.3× 54 0.6× 49 0.8× 37 0.9× 102 3.0× 7 332
W. Amara France 9 420 2.6× 84 0.9× 114 2.0× 29 0.7× 12 0.4× 57 480
Felicité Kamdem Cameroon 11 223 1.4× 13 0.1× 30 0.5× 24 0.6× 71 2.1× 52 407
Sergio Cinza‐Sanjurjo Spain 9 213 1.3× 38 0.4× 48 0.8× 46 1.1× 37 1.1× 74 334
Samira Moughrabi United States 6 301 1.9× 13 0.1× 145 2.5× 59 1.4× 44 1.3× 12 470

Countries citing papers authored by Jeff Nagge

Since Specialization
Citations

This map shows the geographic impact of Jeff Nagge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeff Nagge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeff Nagge more than expected).

Fields of papers citing papers by Jeff Nagge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeff Nagge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeff Nagge. The network helps show where Jeff Nagge may publish in the future.

Co-authorship network of co-authors of Jeff Nagge

This figure shows the co-authorship network connecting the top 25 collaborators of Jeff Nagge. A scholar is included among the top collaborators of Jeff Nagge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeff Nagge. Jeff Nagge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Nagge, Jeff, et al.. (2025). Enhancing Anticoagulation Continuing Professional Development with Experiential Learning. SHILAP Revista de lepidopterología. 7(1). 13–26.
2.
Nagge, Jeff, et al.. (2024). Identifying pseudo-resistant hypertension and optimizing diuretic therapy for confirmed resistant cases in primary care. Canadian Pharmacists Journal / Revue des Pharmaciens du Canada. 157(6). 334–340.
3.
Nagge, Jeff, et al.. (2024). The quality of pharmacist-led community warfarin management across 2 provinces in Canada: A cross-sectional observational study. Canadian Pharmacists Journal / Revue des Pharmaciens du Canada. 157(2). 77–83. 2 indexed citations
4.
Nagge, Jeff, et al.. (2024). Medication therapy problems detected at community pharmacy INR checks. Canadian Pharmacists Journal / Revue des Pharmaciens du Canada. 158(2). 83–89.
5.
Nagge, Jeff, et al.. (2022). Variation in bleeding risk estimates among online calculators. Canadian Family Physician. 68(4). e127–e135. 1 indexed citations
6.
Grindrod, Kelly & Jeff Nagge. (2019). Simplifying QT prolongation for busy clinicians.. PubMed. 65(4). 268–270. 5 indexed citations
7.
Nagge, Jeff, et al.. (2019). Managing hypertension in primary care.. PubMed. 65(10). 725–729. 6 indexed citations
8.
Nagge, Jeff, et al.. (2017). Using a course pilot in the development of an online problem-based learning (PBL) therapeutics course in a post-professional PharmD program. Currents in Pharmacy Teaching and Learning. 10(2). 231–234. 19 indexed citations
9.
Nagge, Jeff, et al.. (2017). Evaluation of a Unique Interprofessional Education Program Involving Medical and Pharmacy Students. American Journal of Pharmaceutical Education. 81(10). 6140–6140. 36 indexed citations
10.
Sridhar, Vikas S., et al.. (2014). Evaluation of an initiation protocol of 4 mg of warfarin for atrial fibrillation in the outpatient setting.. PubMed. 60(11). e535–40. 3 indexed citations
11.
Dhalla, Irfan A., Tara Gomes, Zhan Yao, et al.. (2013). Chlorthalidone Versus Hydrochlorothiazide for the Treatment of Hypertension in Older Adults. Annals of Internal Medicine. 7 indexed citations
12.
Dhalla, Irfan A., Tara Gomes, Zhan Yao, et al.. (2013). Chlorthalidone Versus Hydrochlorothiazide for the Treatment of Hypertension in Older Adults. Annals of Internal Medicine. 158(6). 447–455. 74 indexed citations
13.
Nagge, Jeff, Cynthia A. Jackevicius, Vladimír Džavík, John Ross, & Peter H. Seidelin. (2003). Acute Profound Thrombocytopenia Associated with Eptifibatide Therapy. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 23(3). 374–379. 17 indexed citations
14.
Nagge, Jeff, Mark Crowther, & Jack Hirsh. (2002). Is Impaired Renal Function a Contraindication to the Use of Low-Molecular-Weight Heparin?. Archives of Internal Medicine. 162(22). 2605–2605. 102 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026